Correlation Between Navidea Biopharmaceutica and Cardiff Oncology
Can any of the company-specific risk be diversified away by investing in both Navidea Biopharmaceutica and Cardiff Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Navidea Biopharmaceutica and Cardiff Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Navidea Biopharmaceuticals and Cardiff Oncology, you can compare the effects of market volatilities on Navidea Biopharmaceutica and Cardiff Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Navidea Biopharmaceutica with a short position of Cardiff Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Navidea Biopharmaceutica and Cardiff Oncology.
Diversification Opportunities for Navidea Biopharmaceutica and Cardiff Oncology
-0.41 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Navidea and Cardiff is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Navidea Biopharmaceuticals and Cardiff Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardiff Oncology and Navidea Biopharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Navidea Biopharmaceuticals are associated (or correlated) with Cardiff Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardiff Oncology has no effect on the direction of Navidea Biopharmaceutica i.e., Navidea Biopharmaceutica and Cardiff Oncology go up and down completely randomly.
Pair Corralation between Navidea Biopharmaceutica and Cardiff Oncology
Given the investment horizon of 90 days Navidea Biopharmaceuticals is expected to under-perform the Cardiff Oncology. But the pink sheet apears to be less risky and, when comparing its historical volatility, Navidea Biopharmaceuticals is 1.55 times less risky than Cardiff Oncology. The pink sheet trades about -0.5 of its potential returns per unit of risk. The Cardiff Oncology is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 149.00 in Cardiff Oncology on September 12, 2024 and sell it today you would earn a total of 229.00 from holding Cardiff Oncology or generate 153.69% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 1.14% |
Values | Daily Returns |
Navidea Biopharmaceuticals vs. Cardiff Oncology
Performance |
Timeline |
Navidea Biopharmaceutica |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Cardiff Oncology |
Navidea Biopharmaceutica and Cardiff Oncology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Navidea Biopharmaceutica and Cardiff Oncology
The main advantage of trading using opposite Navidea Biopharmaceutica and Cardiff Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Navidea Biopharmaceutica position performs unexpectedly, Cardiff Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiff Oncology will offset losses from the drop in Cardiff Oncology's long position.Navidea Biopharmaceutica vs. NovaBay Pharmaceuticals | Navidea Biopharmaceutica vs. Cyclacel Pharmaceuticals | Navidea Biopharmaceutica vs. Tenax Therapeutics |
Cardiff Oncology vs. Reviva Pharmaceuticals Holdings | Cardiff Oncology vs. PDS Biotechnology Corp | Cardiff Oncology vs. Reviva Pharmaceuticals Holdings | Cardiff Oncology vs. Eyenovia |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Complementary Tools
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |